Plasma homocysteine is elevated in COPD patients and is related to COPD severity

References

• [AARC] American Association for Respiratory Care1996AARC Clinical Practice Guideline Spirometry 1996 UpdateReprinted from Respir Care41762936
   Google Scholar
• [ATS] American Thoracic Society1995Statement on Standardisation of Spirometry 1994 UpdateAm J Respir Crit Care Med1521107367663792
   PubMed Web of Science ®Google Scholar
• AnderssonAAnkerstJLindgrenA2001Hyperhomocysteinemia and changed plasma thiol redox status in chronic obstructive pulmonary diseaseClin Chem Lab Med392293311350020
   PubMed Web of Science ®Google Scholar
• AnthonisenNRConnettJEEnrightPL2002Hospitalisation and mortality in the Lung Health StudyAm J Respir Crit Care Med1663338912153966
   PubMed Web of Science ®Google Scholar
• BarnesPJ2000Medical progress: chronic obstructive pulmonary diseaseN Engl J Med3432698010911010
   PubMed Web of Science ®Google Scholar
• BodiVSanchisJLlacerA2005Risk Stratification in non-ST elevation acute coronary syndromes; Predictive power of troponin I, C-reactive protein, fibrinogen and total plasma homocysteineInt J Cardio98227783
   PubMed Web of Science ®Google Scholar
• BonaaKHNjolstadIUelandPM2006Homocysteine lowering and cardiovascular events after acute myocardial infarctionN Engl J Med3541515788816531614
   PubMed Web of Science ®Google Scholar
• BroekhuizenRWoutersEFMCreutzbergEC2005Elevated CRP levels mark metabolic and functional impairment in advanced COPDThorax, doi:10.1136/thx.2005.041996.
   Web of Science ®Google Scholar
• BuistS2006Global Standards for the Diagnosis, Management and Prevention of COPD. MCR Vision Inc.
   Google Scholar
• CheungFCheungSM2003Measuring Personality and values across cultures: imported versus indigenous measuresOnline Readings in Psychology and Culture65
   Google Scholar
• CleophasTJHornstraNvan HoogstratenB2000Homocysteine, a risk factor for coronary artery disease or not? A meta-analysisAm J Cardiol86910059A811053715
   PubMed Web of Science ®Google Scholar
• CockburnBNBermanoGBoodramLL2005Gene symbol: IPF1. Disease: MODY 4Hum Genet116653815991313
   PubMedGoogle Scholar
• CrapoRoMorrisAHGardnarRM1981Reference spirometric values using techniques and equipment that meets ATS recommendationsAm Rev Respir Dis123654597271064
   PubMed Web of Science ®Google Scholar
• DahlMVestboJLangeP2007Dahl C-reactive Protein is a Strong Predictor of Prognosis in COPDAm J Respir Crit Care Med1753250517053205
   PubMed Web of Science ®Google Scholar
• DaneshJCollinsRApplebyP1998Direct proinflammatory effects of fibrinogen, C-rective protein, albumin or leukocyte count with coronary heart disease: meta-analyses of prospective studiesJAMA279216568
   Web of Science ®Google Scholar
• DavisonC2004Translation of fixed-response questionnaires for health research with aboriginal people: a discussion of methodsPimatsiwin: A Journal of Aboriginal and Indigenous Community Health2297114
   Google Scholar
• DurgaJvan TitsLJHSchoutenEG2005Effect of lowering of homocysteine levels on inflammatory markers: a randomized controlled trialArch Intern Med16513889415983288
   PubMedGoogle Scholar
• FabiosaJMohantySSmithD1997Conceptual Framework and Software Documentation. Jamaica Technical ManualCARD Technical Report97–TR 33.
   Google Scholar
• GanWQManSFPSenthilselvanA2004Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax595748015223864
   PubMed Web of Science ®Google Scholar
• GoyettePFrosstPRosenblattDS1995Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiencyAm J Hum Genet565105297726158
   PubMed Web of Science ®Google Scholar
• HarrinarineRAbirajVAliA2005Prevalence of COPD in acute medical patients in TrinidadWest Ind Med J54Suppl 246
   Google Scholar
• Homocysteine Studies Collaboration2002Homocysteine and Risk of Ischaemic Heart Disease and Stroke: A Meta-analysisJAMA28820152212387654
   PubMed Web of Science ®Google Scholar
• JonesPWQuirkFHBaveystockCM1991The St. George’s Respiratory QuestionnaireRespir Med5Suppl(B)25311759018
   PubMed Web of Science ®Google Scholar
• KaiSNomuraAMorishimaY2005The effect of smoking related hyperhomocysteinaemia on spirometric declines in chronic obstructive pulmonary disease in elderly JapaneseArch Gerontol Geriatr421172416125804
   PubMed Web of Science ®Google Scholar
• KluchovaZPetrasovaDJoppaP2006The association between oxidative stress and obstructive lung impairment in patients with COPDPhysiol Res56151616497100
   PubMed Web of Science ®Google Scholar
• KluijtmansLAYoungISBorehamCA2003Genetic and nutritional factors contributing to hyperhomocysteinemia in young adultsBlood10172483812642343
   PubMed Web of Science ®Google Scholar
• MillerGJBecklesGLMaudeGH1989Ethnicity and other characteristics predictive of coronary heart disease in a developing community: principal results of the St James Survey, TrinidadInt J Epidemiol184808172621016
   PubMed Web of Science ®Google Scholar
• MuddHLLevyKrausJP2001Disorders of transsulfurationScriverCRBeaudetALSlyWSThe metabolic and molecular bases of inherited diseaseMcGraw HillNew York200756
   Google Scholar
• National Agriculture Library2004National Nutrient Database for Standard Reference [online]. Accessed 15 January 2004. URL: http://www.nal.usda.gov
   Google Scholar
• Pinto-PereiraLClementYDa SilvaCK2002Understanding and use of inhaler medication by asthmatics in specialty care in TrinidadChest12118334012065346
   PubMed Web of Science ®Google Scholar
• RefsumHSmithADUelandN2004Facts and recommendations about total plasma homocysteine determinants: An expert opinionClin Chem5033214709635
   PubMed Web of Science ®Google Scholar
• RimmEBWillettWCHuFB1998Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among womenJAMA2795359649459468
   PubMed Web of Science ®Google Scholar
• SattarNCromptonPCherryL2007Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: a double-blind, placebo-controlled studyArthritis Rheum563831917328057
   PubMed Web of Science ®Google Scholar
• SchroecksnadelKFrickBFieglM2007Hyperhomocysteinaemia and immune activation in patients with cancerClin Chem Lab Med451475317243914
   PubMed Web of Science ®Google Scholar
• ScottPWMullingsRL1998Bronchial asthma deaths in JamaicaWest Indian Med J4712913210097664
   PubMed Web of Science ®Google Scholar
• SeemungalTARDonaldsonGCBhowmikA2000Time course and recovery of exacerbations in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med16116081810806163
   PubMed Web of Science ®Google Scholar
• SeemungalTARDonaldsonGCPaulEA1998Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1571418229603117
   PubMed Web of Science ®Google Scholar
• SinDDLacyPYorkE2004Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med170760515229100
   PubMed Web of Science ®Google Scholar
• SinDDManSFP2003Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary diseaseCirculation10715141912654609
   PubMed Web of Science ®Google Scholar
• VibhutiAArifEDeepakD2007Correlation of oxidative status with BMI and lung function in COPDClin Biochem62[Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• WedzichaJSeemungalTMacCallumP2000Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levelsThromb Haemost84210510959691
   PubMed Web of Science ®Google Scholar
• ZakaiNAKatzRJennyNS2007Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the cardiovascular health studyJ Thromb Haemost321[Epub ahead of print].
   Web of Science ®Google Scholar